NCT02269020

Brief Summary

The main hypothesis of this study is that it is possible to make a unilateral selective dissection of ganglion levels IIa, III and IV using an endoscopic transaxillary approach via the da Vinci robotic system to reduce scarring, while respecting patient safety. Feasibility will be assessed by two combinded criteria: 1) performance of the surgical procedure respecting the different stages of visualization and dissection of key anatomical elements; 2) obtain a minimum of 9 lymph nodes when analyzing pathological evidence of the dissection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Feb 2015

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2014

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 20, 2014

Completed
4 months until next milestone

Study Start

First participant enrolled

February 16, 2015

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2017

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2017

Completed
Last Updated

January 11, 2019

Status Verified

January 1, 2019

Enrollment Period

2.6 years

First QC Date

October 8, 2014

Last Update Submit

January 10, 2019

Conditions

Keywords

Squamous Cell Carcinoma of the Epi-larynx

Outcome Measures

Primary Outcomes (2)

  • Number of patients that had pre-defined key points of the surgical procedure performed

    Were all pre-defined key points of the surgical procedure performed? yes/no Description of the key points (includes (i) axillary approach, (ii) robot arm insertion, (iii) dissection, (iv) closing) of the surgical procedure.

    Day 0

  • Number of lymph nodes dissected

    Determined by analysis of excised tissues.

    Day 0

Secondary Outcomes (12)

  • The duration of surgical site preparation

    Day 0

  • The duration of robot installation / preparation

    Day O

  • Intervention time (between incision and closure by the surgeon)

    Day 0

  • Time in general anesthesia

    Day 0

  • Surgical time (console time for robot-assisted surgery)

    Day 0

  • +7 more secondary outcomes

Other Outcomes (41)

  • The number of ganglions excised at each level.

    expected between day 7 and day 15

  • The number of metastatic ganglions

    expected between day 7 and day 15

  • The presence/absence of capsular rupture

    expected between day 7 and day 15

  • +38 more other outcomes

Study Arms (1)

3 patients cancer of the epi larynx

EXPERIMENTAL

3 patients with squamous cell carcinoma of the epi-larynx Intervention: Neck Dissection

Procedure: Neck Dissection

Interventions

Unilateral Selective Neck Dissection at Lymph Node Levels IIa, III and IV Using a Robot-assisted Transaxillary Approach. The robotic system used is the da Vinci system.

3 patients cancer of the epi larynx

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cancer of the epi-larynx: (i) ranked T1 or T2 in the TNM classification, (ii) supraglottic or glotto-supraglottic location, (iii) CN0 nodal status
  • Absence of distant metastasis (M0)
  • Decision for unilateral endoscopic axillary neck dissection at lymph node levels IIa, III and IV of the Robins classification is retained in a multidisciplinary meeting
  • The patient is available for 12 months of follow-up
  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan

You may not qualify if:

  • Adult under judicial protection or any kind of guardianship
  • Refusal to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient, or breastfeeding
  • Preoperative diagnosis of a second location of cancerous disease
  • Body Mass Index \> 25
  • History of cervical spine surgery
  • History of instability of the cervical spine
  • History of surgery in the shoulder or pre-pectoral region
  • History of ipsilateral neck surgery
  • History of cervical radiotherapy
  • History of breast implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France

Location

MeSH Terms

Conditions

Carcinoma, Squamous Cell

Interventions

Neck Dissection

Condition Hierarchy (Ancestors)

CarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsNeoplasms, Squamous Cell

Intervention Hierarchy (Ancestors)

Lymph Node ExcisionSurgical Procedures, OperativeOtorhinolaryngologic Surgical Procedures

Study Officials

  • Benjamin Lallemant, MD, PhD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2014

First Posted

October 20, 2014

Study Start

February 16, 2015

Primary Completion

September 4, 2017

Study Completion

September 14, 2017

Last Updated

January 11, 2019

Record last verified: 2019-01

Locations